Equity Analysis

Quarterly Results

    Laurus Labs Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    540222
    INE947Q01028
    79.1918408
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    LAURUSLABS
    111.41
    26189.66
    EPS(TTM)
    Face Value()
    Div & Yield %:
    4.36
    2
    0.16
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales1184.851116.931414.52
Other Operating Income0.000.000.00
Other Income 11.899.3024.09
Total Income1196.741126.231438.61
Total Expenditure 1003.02955.541143.41
PBIDT193.72170.69295.20
Interest 44.6940.8941.99
PBDT149.03129.80253.21
Depreciation90.9491.0088.90
Tax21.9717.2645.94
Fringe Benefit Tax0.000.000.00
Deferred Tax-6.32-7.24-2.95
Reported Profit After Tax42.4428.78121.32
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item42.4428.78121.32
EPS (Unit Curr.)0.790.532.25
EPS (Adj) (Unit Curr.)0.790.532.25
Calculated EPS (Unit Curr.)0.790.532.25
Calculated EPS (Adj) (Unit Curr.)0.790.532.25
Calculated EPS (Ann.) (Unit Curr.)3.152.149.00
Calculated EPS (Adj) (Ann.) (Unit Curr.)3.152.149.00
Book Value (Unit Curr.)0.000.000.00
Dividend (%)20.000.000.00
Equity107.83107.83107.79
Reserve & Surplus4161.870.000.00
Face Value2.002.002.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)16.3515.2820.87
PBDTM(%)12.5811.6217.90
PATM(%)3.582.588.58
Dividend Per Share(Rs)0.400.000.00
Diluted EPS0.790.532.25